Ibu and Juluca drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ibu (ibuprofen) and Juluca (dolutegravir sodium; rilpivirine hydrochloride). Common drug interactions include nephropathy among females and emotional distress among males.
The phase IV clinical study analyzes what interactions people have when they take Ibu and Juluca. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.
What is Ibu?
Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,531 Ibu users. Check the latest studies of Ibu.
What is Juluca?
Juluca has active ingredients of dolutegravir sodium; rilpivirine hydrochloride. eHealthMe is studying from 1,732 Juluca users. Check the latest studies of Juluca.
46 people who take Ibu and Juluca together, and have interactions are studied.

What are the common drug interactions of Ibu and Juluca, by gender? *:
female:
- Nephropathy (damage to or disease of a kidney)
- Rash
- Renal disorder (kidney disease)
- Renal pain (kidney pain)
- Respiratory distress (difficulty in breathing)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Suicidal ideation
- Suicide attempt
- Tooth fracture
- Urethral stenosis (narrowing of the urethra, may cause decreased urine output)
male:
- Emotional distress
- Anxiety
- Multiple fractures
- Renal impairment (severely reduced kidney function)
- Rib fracture
- Tooth disorder (tooth disease)
- Tooth loss
- Bone loss
- Gait disturbance
- Osteonecrosis (death of bone)
What are the common drug interactions of Ibu and Juluca, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Emotional distress
- Quality of life decreased
- Bone density decreased
- Osteoporosis (bones weak and more likely to break)
- Forearm fracture (fracture in between wrist to elbow)
- General physical health deterioration (weak health status)
- Hyperkalaemia (damage to or disease of the kidney)
- Renal failure (kidney dysfunction)
50-59:
- Emotional distress
- Chronic kidney disease
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Renal failure (kidney dysfunction)
- Bone density decreased
- Osteoporosis (bones weak and more likely to break)
- Tooth loss
- Arthralgia (joint pain)
- Depression
60+:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Neuropathy peripheral (surface nerve damage)
- Renal impairment (severely reduced kidney function)
- Bone pain
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Contusion (a type of hematoma of tissue in which capillaries)
- Dyspepsia (indigestion)
- Fatigue (feeling of tiredness)
- Gait disturbance
What are the existing conditions these people have? *
- Hiv Infection: 43 people, 93.48%
- Bacterial Infection: 7 people, 15.22%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 15.22%
- High Blood Pressure: 7 people, 15.22%
- Inflammation: 7 people, 15.22%
- Hypersensitivity: 5 people, 10.87%
- Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 5 people, 10.87%
- Fungal Infection: 5 people, 10.87%
- Laxative Supportive Care: 5 people, 10.87%
- Stress And Anxiety: 5 people, 10.87%
* Approximation only. Some reports may have incomplete information.
Do you take Ibu and Juluca?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ibu and Juluca:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ibu:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Juluca:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ibu and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Juluca and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
- Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
How the study uses the data?
The study uses data from the FDA. It is based on ibuprofen and dolutegravir sodium; rilpivirine hydrochloride (the active ingredients of Ibu and Juluca, respectively), and Ibu and Juluca (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Progesterone and Femhrt - 2 seconds ago
- Rashes in Estrostep Fe, how severe and when it was recovered? - 3 seconds ago
- Sunitinib Malate and General Ill Feeling for Men aged 60+ - 5 seconds ago
- Sunitinib Malate and Malaise for Men aged 60+ - 6 seconds ago
- Cough Aggravated and drugs of ingredients of tralokinumab - 6 seconds ago
- Could Topiramate cause Weight Increased? - 8 seconds ago
- Drug interactions of Epipen and Demerol - 9 seconds ago
- Death and drugs of ingredients of sitagliptin phosphate - 12 seconds ago
- Multihance and Stress And Anxiety for Women aged 20-29 - 13 seconds ago
- Multihance and Anxiolytic Therapy for Women aged 20-29 - 13 seconds ago